<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">101001</article-id><article-id pub-id-type="doi">10.17816/kazmj101001</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>New medicines</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Новые лекарственные средства</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">New medicines. Vol 76, No 3 (1995)</article-title><trans-title-group xml:lang="ru"><trans-title>Новые лекарственные средства. Том 76, № 3 (1995)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Artemiev</surname><given-names>A. I.</given-names></name><name xml:lang="ru"><surname>Артемьев</surname><given-names>А. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Astrakhanova</surname><given-names>M. M.</given-names></name><name xml:lang="ru"><surname>Астраханова</surname><given-names>М. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Alekseev</surname><given-names>K. V.</given-names></name><name xml:lang="ru"><surname>Алексеев</surname><given-names>К. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kiseleva</surname><given-names>G. S.</given-names></name><name xml:lang="ru"><surname>Киселева</surname><given-names>Г. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Anikina</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Аникина</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Elagina</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Елагина</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nasybullina</surname><given-names>N. M.</given-names></name><name xml:lang="ru"><surname>Насыбуллина</surname><given-names>Н. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Prikhodko</surname><given-names>L. A.</given-names></name><name xml:lang="ru"><surname>Приходько</surname><given-names>Л. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sollogub</surname><given-names>L. V.</given-names></name><name xml:lang="ru"><surname>Соллогуб</surname><given-names>Л. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Truckman</surname><given-names>Y. G.</given-names></name><name xml:lang="ru"><surname>Тракман</surname><given-names>Ю. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Usmanov</surname><given-names>U. H.</given-names></name><name xml:lang="ru"><surname>Усманов</surname><given-names>У. Х.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Abramovich</surname><given-names>R. A.</given-names></name><name xml:lang="ru"><surname>Абрамович</surname><given-names>Р. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ordzhonikidze</surname><given-names>M. K.</given-names></name><name xml:lang="ru"><surname>Орджоникидзе</surname><given-names>М. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="1995-05-15" publication-format="electronic"><day>15</day><month>05</month><year>1995</year></pub-date><volume>76</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>269</fpage><lpage>270</lpage><history><date date-type="received" iso-8601-date="2022-02-17"><day>17</day><month>02</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-02-17"><day>17</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1995, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1995, Эко-Вектор</copyright-statement><copyright-year>1995</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/101001">https://kazanmedjournal.ru/kazanmedj/article/view/101001</self-uri><abstract xml:lang="en"><p>One of the main directions of scientific research of the Research Institute of Pharmacy is the development of new effective medicines in the form of various solutions, ointments, suppositories, tablets, granules, powders, extracts intended for the treatment of a wide variety of diseases. The need of the population for anti-inflammatory drugs is satisfied by 85%, of which 28% are domestic drugs. Therefore, in recent years, the Research Institute of Pharmacy has been intensively working to create new dosage forms of piroxicam (gel and ointment) that have minimal side effects with a maximum of therapeutic activity of anti-inflammatory action.</p></abstract><trans-abstract xml:lang="ru"><p>Одним из основных направлений научных исследований НИИ фармации является разработка новых эффективных лекарственных средств в форме различных растворов, мазей, суппозиториев, таблеток, гранул, порошков, экстрактов, предназначенных для лечения самых разнообразных заболеваний. Потребность населения в противовоспалительных средствах удовлетворяется на 85%, из них 28% составляют отечественные препараты. Поэтому в последние годы в НИИ фармации ведется интенсивная работа по созданию новых лекарственных форм пироксикама (гель и мазь), обладающих минимальными побочными эффектами при максимуме терапевтической активности противовоспалительного действия.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Kazan Medical archive</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Казанский медицинский архив</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list/></back></article>
